<DOC>
	<DOC>NCT02433847</DOC>
	<brief_summary>Effect of mosapride 30mg/day on the small bowel and colon transit time in patients with chronic constipation or constipated irritable bowel syndrome.</brief_summary>
	<brief_title>Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Mosapride</mesh_term>
	<criteria>Functional constipation or constipated irritable bowel syndrome patients according to Rome III criteria Intolerable or hypersensitive to mosapride Known Parkinson's ds Cardio or cerebrovascular disease within 3 months Malignancy requiring surgery or chemotherapy or radiation within 5 years History of GI surgeries except hernia repair, appendectomy, primary closure due to perforation Refractory diabetes mellitus/hypertension/thyroid diseases Symptomatic heart failure, renal failure, arrhythmia</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>mosapride</keyword>
</DOC>